Skip to main content

Table 2 Perioperative course of patients with CRLMs in the three age groups

From: Multidisciplinary treatment for colorectal liver metastases in elderly patients

Variable ≤ 64 years 65-74 years ≥ 75 years p value
(n = 265) (n = 151) (n = 46)
Major hepatectomy, n (%) 53 (20.0) 36 (23.8) 9 (19.6) 0.628
 Operation time, min 305.0 (60-953) 275.0 (95-695) 263.0 (115-810) 0.194
 Blood loss, ml 390 (20-2640) 300 (10-6530) 265 (5-1910) 0.023
Surgical margin: positive, n (%) 15 (5.7) 8 (5.3) 2 (4.3) 0.934
 Preoperative chemotherapy, n (%) 107 (40.4) 47 (31.1) 12 (26.1) 0.057
 Adjuvant chemotherapy, n (%) 144 (54.3) 65 (43.5) 9 (19.6) < 0.001
Complication     
 Major complications, n (%) 17 (6.4) 9 (6.0) 3 (6.5) 0.981
 Biliary leakage, n (%) 9 (3.4) 6 (4.0) 2 (4.4) 0.926
 Intraabdominal hemorrhage, n (%) 3 (1.1) 2 (1.3) 1 (2.1) 0.847
 Surgical site infection, n (%) 24 (9.1) 14 (9.3) 3 (6.5) 0.837
 Postoperative hospital stay, days 14 (5-160) 15 (8-372) 15 (8-45) 0.338
 Mortality, n 0 0 0  
  1. Continuous data expressed as median (range)
  2. CRLMs colorectal cancer liver metastases.